JP6385095B2 - Blood purification equipment - Google Patents

Blood purification equipment Download PDF

Info

Publication number
JP6385095B2
JP6385095B2 JP2014064478A JP2014064478A JP6385095B2 JP 6385095 B2 JP6385095 B2 JP 6385095B2 JP 2014064478 A JP2014064478 A JP 2014064478A JP 2014064478 A JP2014064478 A JP 2014064478A JP 6385095 B2 JP6385095 B2 JP 6385095B2
Authority
JP
Japan
Prior art keywords
blood
plasma
blood purification
separation circuit
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014064478A
Other languages
Japanese (ja)
Other versions
JP2015186507A (en
JP2015186507A5 (en
Inventor
裕也 五反田
裕也 五反田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Med Tech Inc
Asahi Kasei Medical Co Ltd
Original Assignee
Med Tech Inc
Asahi Kasei Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Med Tech Inc, Asahi Kasei Medical Co Ltd filed Critical Med Tech Inc
Priority to JP2014064478A priority Critical patent/JP6385095B2/en
Priority to CN201510138237.0A priority patent/CN104941019B/en
Publication of JP2015186507A publication Critical patent/JP2015186507A/en
Publication of JP2015186507A5 publication Critical patent/JP2015186507A5/ja
Application granted granted Critical
Publication of JP6385095B2 publication Critical patent/JP6385095B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/0021Special media to be introduced, removed or treated removed from and reintroduced into the body, e.g. after treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0413Blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/18General characteristics of the apparatus with alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/70General characteristics of the apparatus with testing or calibration facilities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/75General characteristics of the apparatus with filters

Description

本発明は、血液浄化装置に関する。   The present invention relates to a blood purification apparatus.

患者から血液を取り出し、当該血液から病因物質を分離し、血液を浄化して体内に戻す治療を総称して血液浄化療法という。血液浄化療法は、血液浄化装置を用いて行われ、血液浄化装置は、中空糸膜などの分離膜を用いて患者の血液から所定成分を分離する血液浄化器と、血液を当該血液浄化器に供給し血液浄化器から患者に戻す血液回路と、血液浄化器で分離された成分を流す分離回路等を備えている。分離膜を有する血液浄化器には、治療の目的に応じて、血液から主に余分な水分や老廃物を分離する血液濾過器、血液から主に血漿を分離する血漿分離器、血漿中の血漿成分のアルブミン区画とグロブリン区画とを分離する血漿成分分離器等がある。血液濾過療法、血液透析療法、血液濾過透析療法、持続的血液透析療法、持続的血液濾過療法および持続的血液濾過透析療法などの血液中の主に水分を分離する療法には、血液濾過器が用いられ、単純血漿交換療法、二重膜濾過血漿交換療法および血漿吸着療法などの血液中の血漿を交換する療法には、血漿分離器や血漿成分分離器が用いられる。このように血液浄化器は治療毎に異なるものが用いられるが、一般的にこれらの血液浄化器と血液回路の接続仕様は、統一されている。   The treatment for removing blood from a patient, separating the etiological agent from the blood, purifying the blood, and returning it to the body is called blood purification therapy. The blood purification therapy is performed using a blood purification device, and the blood purification device uses a separation membrane such as a hollow fiber membrane to separate a predetermined component from the patient's blood, and the blood to the blood purification device. A blood circuit that supplies and returns the blood from the blood purifier to the patient, a separation circuit that flows the components separated by the blood purifier, and the like are provided. A blood purifier having a separation membrane includes a blood filter that mainly separates excess water and waste from blood according to the purpose of treatment, a plasma separator that mainly separates plasma from blood, and plasma in plasma There are plasma component separators that separate the albumin and globulin compartments of the components. For the therapies that mainly separate water in the blood, such as hemofiltration therapy, hemodialysis therapy, hemofiltration dialysis therapy, continuous hemodialysis therapy, continuous hemofiltration therapy and continuous hemofiltration dialysis therapy, a hemofilter is used. Plasma separators and plasma component separators are used for the exchange of plasma in blood, such as simple plasma exchange therapy, double membrane filtration plasma exchange therapy, and plasma adsorption therapy. In this way, different blood purifiers are used for each treatment, but generally, the connection specifications of these blood purifiers and blood circuits are unified.

特開2013−022021号公報JP 2013-022021 A

前述したように血液浄化器は多種存在するが、血液回路に対する接続仕様は統一されているため、血液浄化器の付け間違いが生じる可能性がある。血液浄化器の付け間違いが起きると、治療効果が得られなくなる。   As described above, there are various types of blood purifiers, but since the connection specifications for the blood circuit are unified, there is a possibility that an error in attaching the blood purifier may occur. If a blood purifier is misplaced, the therapeutic effect cannot be obtained.

例えば血液濾過療法等の主に水分を分離する療法時に、血液濾過器ではなく、誤って血漿分離器や血漿成分分離器を接続した場合、患者の血液中の水分だけではなく、他の血漿成分も分離してしまうため、血液中の成分バランスが崩れてしまう。また、血漿交換療法時に、血漿分離器ではなく、誤って血液濾過器を接続した場合、患者の血液から血漿が十分に抜けないため、治療効果が得られず、また血液中に新鮮凍結血漿を補液するので、血液成分バランスも崩してしまう。   For example, if a plasma separator or plasma component separator is mistakenly connected instead of a hemofilter at the time of mainly separating water such as blood filtration therapy, not only the moisture in the patient's blood but also other plasma components Is also separated, and the balance of the components in the blood is lost. In addition, if a blood filter is connected by mistake instead of a plasma separator during plasma exchange therapy, the plasma will not be sufficiently removed from the patient's blood, resulting in no therapeutic effect and fresh frozen plasma in the blood. Since the fluid is replaced, the blood component balance is lost.

本発明はかかる点に鑑みてなされたものであり、血液浄化器の付け間違いを検出可能な血液浄化装置を提供することをその目的とする。   This invention is made | formed in view of this point, and it aims at providing the blood purification apparatus which can detect the attachment mistake of a blood purifier.

本発明者らは、上記課題を解決するため鋭意検討した結果、分離回路を流れる液中の所定の血漿成分の有無を検出することで、上記課題が解決されることを見出し、本発明をなすに至った。すなわち、本発明は下記(1)〜(7)を提供する。   As a result of intensive studies to solve the above problems, the present inventors have found that the above problems can be solved by detecting the presence or absence of a predetermined plasma component in the liquid flowing through the separation circuit. It came to. That is, the present invention provides the following (1) to (7).

(1)血液から所定成分を分離する血液浄化器と、前記血液浄化器で分離された所定成分の液が流れる分離回路と、前記分離回路の透過光量を検出するセンサと、前記センサが検出する透過光量に基づいて、前記分離回路の液中における所定の血漿成分の有無を検出する血漿成分検出部と、を備え、前記血液浄化装置は、前記分離回路の液に前記血漿成分が含まれる血液浄化処理を行うものであり、前記血液浄化処理時に前記血漿成分検出部により前記血漿成分が検出されない場合に、警報を出す、血液浄化装置。
(2)血液から所定成分を分離する血液浄化器と、前記血液浄化器で分離された所定成分の液が流れる分離回路と、前記分離回路の透過光量を検出するセンサと、前記センサが検出する透過光量に基づいて、前記分離回路の液中における所定の血漿成分の有無を検出する血漿成分検出部と、を備え、前記血液浄化装置は、前記分離回路の液に前記血漿成分が含まれない血液浄化処理を行うものであり、前記血液浄化処理時に前記血漿検出部により前記血漿成分が検出された場合に、警報を出す、血液浄化装置。
(3)血液から所定成分を分離する血液浄化器と、前記血液浄化器で分離された所定成分の液が流れる分離回路と、前記分離回路の透過光量を検出するセンサと、前記センサが検出する透過光量に基づいて、前記分離回路の液中における所定の血漿成分の有無を検出する血漿成分検出部と、を備え、前記血液浄化装置は、複数の血液浄化療法に応じた複数の血液浄化処理を行うものであり、前記分離回路の液に前記血漿成分が含まれる血液浄化処理を行っている場合には、前記血漿成分検出部により前記血漿成分が検出されない時に警報を出し、前記分離回路の液に前記血漿成分が含まれない血液浄化処理を行っている場合には、前記血漿成分検出部により前記血漿成分が検出された時に警報を出す、血液浄化装置。
(4)前記センサは、波長が200nm〜550nmの透過光を検出するセンサである、(1)〜(3)のいずれかに記載の血液浄化装置。
(5)前記分離回路の液に前記血漿成分が含まれない血液浄化処理は、限外濾過療法、血液濾過療法、血液透析療法、血液濾過透析療法、持続的血液透析療法、持続的血液濾過療法および持続的血液濾過透析療法のいずれかである、(2)又は(3)に記載の血液浄化装置。
(6)前記分離回路の液に前記血漿成分が含まれる血液浄化処理は、単純血漿交換療法、二重膜濾過血漿交換療法および血漿吸着療法のいずれかである、(1)又は(3)に記載の血液浄化装置。
(1) A blood purifier that separates a predetermined component from blood, a separation circuit through which a liquid of the predetermined component separated by the blood purifier flows, a sensor that detects the amount of light transmitted through the separation circuit, and the sensor detects A plasma component detection unit that detects the presence or absence of a predetermined plasma component in the liquid of the separation circuit based on the amount of transmitted light, and the blood purification device includes blood in which the plasma component is contained in the liquid of the separation circuit A blood purification apparatus that performs a purification process and issues an alarm when the plasma component detection unit does not detect the plasma component during the blood purification process .
(2) A blood purifier that separates a predetermined component from blood, a separation circuit through which a liquid of the predetermined component separated by the blood purifier flows, a sensor that detects the amount of light transmitted through the separation circuit, and the sensor detects A plasma component detector that detects the presence or absence of a predetermined plasma component in the liquid of the separation circuit based on the amount of transmitted light, and the blood purification device does not contain the plasma component in the liquid of the separation circuit A blood purification apparatus that performs blood purification processing and issues an alarm when the plasma component is detected by the plasma detection unit during the blood purification processing .
(3) A blood purifier that separates a predetermined component from blood, a separation circuit through which a liquid of the predetermined component separated by the blood purifier flows, a sensor that detects the amount of light transmitted through the separation circuit, and the sensor detects A plasma component detector that detects the presence or absence of a predetermined plasma component in the liquid of the separation circuit based on the amount of transmitted light, and the blood purification device includes a plurality of blood purification processes according to a plurality of blood purification therapies When the blood purification process in which the plasma component is contained in the liquid of the separation circuit is performed, an alarm is issued when the plasma component is not detected by the plasma component detection unit, and the separation circuit A blood purification apparatus that issues an alarm when the plasma component is detected by the plasma component detection unit when a blood purification process in which the plasma component is not contained in the liquid is performed .
(4) The blood purification apparatus according to any one of (1) to (3) , wherein the sensor is a sensor that detects transmitted light having a wavelength of 200 nm to 550 nm.
(5) Blood purification treatment in which the plasma component is not contained in the liquid of the separation circuit includes ultrafiltration therapy, hemofiltration therapy, hemodialysis therapy, hemofiltration dialysis therapy, continuous hemodialysis therapy, and continuous hemofiltration therapy And (2) or (3) .
(6) The blood purification treatment in which the plasma component is contained in the liquid of the separation circuit is one of simple plasma exchange therapy, double membrane filtration plasma exchange therapy, and plasma adsorption therapy. (1) or (3) The blood purification apparatus as described.

本発明によれば、血液浄化装置における血液浄化器の付け間違いを検出できるので、目的に合った治療を適正に行うことができる。   According to the present invention, it is possible to detect a mistake in attaching the blood purifier in the blood purification apparatus, and therefore it is possible to appropriately perform treatment suitable for the purpose.

限外濾過療法を行う血液浄化装置の概略を示す説明図である。It is explanatory drawing which shows the outline of the blood purification apparatus which performs ultrafiltration therapy. 血漿センサの構成の概略を示す説明図である。It is explanatory drawing which shows the outline of a structure of a plasma sensor. 血液濾過療法を行う血液浄化装置の概略を示す説明図である。It is explanatory drawing which shows the outline of the blood purification apparatus which performs blood filtration therapy. 血液透析療法を行う血液浄化装置の概略を示す説明図である。It is explanatory drawing which shows the outline of the blood purification apparatus which performs hemodialysis therapy. 血液濾過透析療法を行う血液浄化装置の概略を示す説明図である。It is explanatory drawing which shows the outline of the blood purification apparatus which performs hemofiltration dialysis therapy. 単純血漿交換療法を行う血液浄化装置の概略を示す説明図である。It is explanatory drawing which shows the outline of the blood purification apparatus which performs simple plasma exchange therapy. 二重濾過血漿浄化療法を行う血液浄化装置の概略を示す説明図である。It is explanatory drawing which shows the outline of the blood purification apparatus which performs double filtration plasma purification therapy. 血漿吸着療法を行う血液浄化装置の概略を示す説明図である。It is explanatory drawing which shows the outline of the blood purification apparatus which performs plasma adsorption therapy.

以下、図面を参照して、本発明の好ましい実施の形態について説明する。図1は、本実施の形態に係る、限外濾過療法を行う血液浄化装置1の構成の概略を示す説明図である。   Hereinafter, preferred embodiments of the present invention will be described with reference to the drawings. FIG. 1 is an explanatory diagram showing an outline of the configuration of a blood purification apparatus 1 that performs ultrafiltration therapy according to the present embodiment.

血液浄化装置1は、例えば血液濾過器10と、患者から取り出された血液を血液濾過器10に送る脱血回路11と、血液濾過10から患者に血液を戻す返血回路12と、血液濾過器10により血液から分離された所定成分を排液する分離回路13を有している。   The blood purification apparatus 1 includes, for example, a blood filter 10, a blood removal circuit 11 that sends blood taken from a patient to the blood filter 10, a blood return circuit 12 that returns blood to the patient from the blood filter 10, and a blood filter 10 has a separation circuit 13 for draining a predetermined component separated from blood by 10.

血液濾過器10は、例えば血液中の主に水分を分離する分離膜としての中空糸膜20を有している。血液濾過器10は、脱血回路11から流入した血液を、中空糸膜20の一次側に流し返血回路12へ流出させ、その際に血液中の主に水分が中空糸膜20の二次側に流出して分離される。 The blood filter 10 has, for example, a hollow fiber membrane 20 as a separation membrane that mainly separates water in blood. The blood filter 10 causes the blood flowing in from the blood removal circuit 11 to flow to the primary side of the hollow fiber membrane 20 and flow out to the blood return circuit 12, and at that time, mainly water in the blood is secondary to the hollow fiber membrane 20. To the side and separated.

脱血回路11及び返血回路12は、例えば軟質のチューブにより構成されている。脱血回路11には、例えば流路のチューブを外側から扱いて液送する血液ポンプ30と、気泡を排出するためのドリップチャンバ31と、流路を流れる血液中に抗凝固薬を注入するためのシリンジポンプ32等が設けられている。ドリップチャンバ31には、例えば血液濾過器10の入口圧を測定する入口圧センサ33が設けられている。   The blood removal circuit 11 and the blood return circuit 12 are configured by, for example, a soft tube. In the blood removal circuit 11, for example, a blood pump 30 for handling and feeding a tube of a flow channel from the outside, a drip chamber 31 for discharging bubbles, and an anticoagulant injecting blood into the blood flowing through the flow channel The syringe pump 32 and the like are provided. The drip chamber 31 is provided with an inlet pressure sensor 33 that measures the inlet pressure of the blood filter 10, for example.

返血回路12には、例えばドリップチャンバ40と、気泡検知器41と、クランプバルブ42と、静脈圧センサ43等が設けられている。   The blood return circuit 12 is provided with, for example, a drip chamber 40, a bubble detector 41, a clamp valve 42, a venous pressure sensor 43, and the like.

分離回路13は、例えば軟質チューブにより構成されている。分離回路13は、血液濾過器10の中空糸膜20の二次側に接続されている。分離回路13には、濾過圧センサ50と、光センサ51と,ポンプ52と、廃液容器53等が設けられている。   The separation circuit 13 is constituted by a soft tube, for example. The separation circuit 13 is connected to the secondary side of the hollow fiber membrane 20 of the blood filter 10. The separation circuit 13 is provided with a filtration pressure sensor 50, an optical sensor 51, a pump 52, a waste liquid container 53, and the like.

光センサ51は、分離回路13の透過光量を検出する。光センサ51は、例えば図2に示すように発光部60と、受光部61と、それらを支持する支持部材62と、センサ制御部63を有している。発光部60と受光部61の間には、分離回路13のチューブを装着できる。   The optical sensor 51 detects the amount of light transmitted through the separation circuit 13. For example, as shown in FIG. 2, the optical sensor 51 includes a light emitting unit 60, a light receiving unit 61, a support member 62 that supports them, and a sensor control unit 63. A tube of the separation circuit 13 can be attached between the light emitting unit 60 and the light receiving unit 61.

発光部60は、所定の血漿成分、例えば蛋白質、糖質、脂質、その他の無機イオンなど(以下、単に「血漿成分」という。)の吸収スペクトルのピークを含む所定の波長の光を出力できる。受光部61は、発光部60から出力され分離回路13を通過した、血漿成分の吸収スペクトルのピークを含む例えば200nm〜550nmの波長の透過光を受光できる。センサ制御部63は、発光部60と受光部61の動作を制御し、発光部60に所定の波長の光を発光させ、受光部61によりその透過光量を検出できる。なお、血漿は、例えば水91%、蛋白質7%、糖質0.1%、脂質1%、その他無機イオン0.9%の組成を有する。   The light emitting unit 60 can output light having a predetermined wavelength including a peak of an absorption spectrum of a predetermined plasma component, such as protein, carbohydrate, lipid, and other inorganic ions (hereinafter simply referred to as “plasma component”). The light receiving unit 61 can receive transmitted light having a wavelength of, for example, 200 nm to 550 nm including the peak of the absorption spectrum of the plasma component that has been output from the light emitting unit 60 and passed through the separation circuit 13. The sensor control unit 63 controls the operation of the light emitting unit 60 and the light receiving unit 61, causes the light emitting unit 60 to emit light having a predetermined wavelength, and allows the light receiving unit 61 to detect the amount of transmitted light. The plasma has a composition of, for example, 91% water, 7% protein, 0.1% carbohydrate, 1% lipid, and 0.9% other inorganic ions.

光センサ51により検出された分離回路13の透過光量の情報は、血漿成分検出部としての制御装置70に出力できる。分離回路13に血漿成分が流れていなければ、分離回路13を透過する光は減衰せず、分離回路13に血漿成分が流れていれば、分離回路13を通過する光は血漿成分に吸収され減衰する。よって、制御装置70は、光センサ51が検出する透過光量に基づいて、分離回路13の液中の血漿成分の有無を検出できる。   Information on the transmitted light amount of the separation circuit 13 detected by the optical sensor 51 can be output to the control device 70 as a plasma component detection unit. If the plasma component is not flowing through the separation circuit 13, the light transmitted through the separation circuit 13 is not attenuated. If the plasma component is flowing through the separation circuit 13, the light passing through the separation circuit 13 is absorbed and attenuated by the plasma component. To do. Therefore, the control device 70 can detect the presence or absence of plasma components in the liquid of the separation circuit 13 based on the transmitted light amount detected by the optical sensor 51.

また、限外濾過療法の場合、正しく血液濾過器10を取り付けている場合には、分離回路13に血漿成分は流れず、誤って血漿分離器や血漿成分分離器を取り付けてしまった場合には、分離回路13に血漿成分が流れる。よって、制御装置70は、正しい血液濾過器10が取り付けられているか否かを判定できる。また、制御装置70は、分離回路13に血漿成分が流れている場合、つまり正しい血液濾過器10が取り付けられていない場合に、警報を発することができる。かかる警報は、例えば音、光、画面表示等により使用者に異常を知らせるものであってもよい。また、このとき、制御装置70は、自動的に各ポンプ30、52等を停止し、クランプバルブ42を閉塞するなどして、血液浄化装置1を安全な状態に制御してもよい。制御装置70は、血液浄化器の取り付けの適否を判定する判定部71と、警報を発する警報出力部72を有している。   In the case of ultrafiltration therapy, when the blood filter 10 is correctly attached, the plasma component does not flow into the separation circuit 13, and the plasma separator or the plasma component separator is mistakenly attached. The plasma component flows into the separation circuit 13. Therefore, the control device 70 can determine whether or not the correct blood filter 10 is attached. In addition, the control device 70 can issue an alarm when a plasma component is flowing in the separation circuit 13, that is, when the correct blood filter 10 is not attached. Such an alarm may notify the user of an abnormality by, for example, sound, light, screen display, or the like. At this time, the control device 70 may control the blood purification device 1 to a safe state by automatically stopping the pumps 30 and 52 and closing the clamp valve 42. The control device 70 includes a determination unit 71 that determines whether or not the blood purifier is attached and an alarm output unit 72 that issues an alarm.

制御装置70は、その他、血液ポンプ30、気泡検知器41、ポンプ52、光センサ51等の各装置の動作を制御して血液浄化処理を実行している。制御装置70は、汎用コンピュータと同様にCPU、メモリ等を有し、予めメモリに記録されたプログラムを実行して、血液浄化療法を実行できる。   In addition, the control device 70 controls the operation of each device such as the blood pump 30, the bubble detector 41, the pump 52, and the optical sensor 51 to execute blood purification processing. The control device 70 has a CPU, a memory, and the like, like a general-purpose computer, and can execute blood purification therapy by executing a program recorded in advance in the memory.

以上に記載の血液浄化装置1で行われる限外濾過療法では、患者の血液が血液分離器10に供給され、主に水分が分離されて患者に戻される。分離回路13には、分離された主に水分が流れ廃液容器53に排液される。このとき、光センサ51により分離回路13の透過光量がモニタリングされ、その情報が制御装置70に出力され、制御装置70は、その透過光量の情報に基づいて、分離回路13の液中の血漿成分の有無を検出する。限外濾過療法において分離回路13で検知されないはずの血漿成分が検出された場合には、制御装置70は、誤った種類の血液浄化器が取り付けられていると判定し、その警報を発する。   In the ultrafiltration therapy performed in the blood purification apparatus 1 described above, the patient's blood is supplied to the blood separator 10, and water is mainly separated and returned to the patient. In the separation circuit 13, mainly separated water flows and is discharged to the waste liquid container 53. At this time, the amount of light transmitted through the separation circuit 13 is monitored by the optical sensor 51, and the information is output to the control device 70. The control device 70, based on the information on the amount of transmitted light, plasma components in the liquid of the separation circuit 13 The presence or absence of is detected. When a plasma component that should not be detected by the separation circuit 13 is detected in the ultrafiltration therapy, the control device 70 determines that an incorrect type of blood purifier is attached, and issues an alarm.

本実施の形態によれば、光センサ51及び制御装置70により、分離回路13の液中の血漿成分を検知できるので、血液浄化器の付け間違いを検出できる。よって、目的に合った治療を適正に行うことができる。   According to the present embodiment, since the plasma component in the liquid of the separation circuit 13 can be detected by the optical sensor 51 and the control device 70, it is possible to detect a mistake in attaching the blood purifier. Therefore, treatment suitable for the purpose can be appropriately performed.

上記実施形態は、血液浄化装置1が限外濾過療法を行うものであったが、同様に血液中の血漿成分以外の主に水分や老廃物を分離する血液濾過器を用いる血液濾過療法、持続的血液濾過療法、血液透析療法、持続的血液透析療法、血液濾過透析療法および持続的血液濾過透析療法等を行う血液浄化装置にも本発明は適用できる。   In the above-described embodiment, the blood purification apparatus 1 performs ultrafiltration therapy. Similarly, blood filtration therapy using a blood filter that separates mainly water and waste products other than plasma components in blood, continuous The present invention can also be applied to blood purification apparatuses that perform static hemofiltration therapy, hemodialysis therapy, continuous hemodialysis therapy, hemofiltration dialysis therapy, continuous hemofiltration dialysis therapy, and the like.

例えば血液濾過療法を行う血液浄化装置1は、例えば図3に示すように補液回路80がドリップチャンバ40に接続され、補液回路80には、補液ポンプ81、補液貯留部82が設けられている。その他の構成は、上述の限外濾過療法を行う血液浄化装置1と同様であり、同じ構成については同じ符号を用いて説明を省略する。血液濾過療法では、血液処理の際に補液貯留部82から補液回路80を通じて補液が血液に補充される。かかる血液浄化装置1においても、正しく血液濾過器10が取り付けられている場合には、分離回路13の液中に血漿成分が含まれず、誤って血漿分離器等が取り付けられている場合には、分離回路13の液中に血漿成分が含まれるので、光センサ51及び制御装置70により、分離回路13の液中の血漿成分の有無を検出することにより、血液浄化器の付け間違いを検出できる。   For example, in the blood purification apparatus 1 that performs blood filtration therapy, a replacement fluid circuit 80 is connected to the drip chamber 40 as shown in FIG. 3, for example, and a replacement fluid pump 81 and a replacement fluid reservoir 82 are provided in the replacement fluid circuit 80. Other configurations are the same as those of the blood purification device 1 that performs the ultrafiltration therapy described above, and the same components are denoted by the same reference numerals and description thereof is omitted. In blood filtration therapy, the blood is supplemented with the replacement fluid from the replacement fluid reservoir 82 through the replacement fluid circuit 80 during blood processing. Also in the blood purification apparatus 1, when the blood filter 10 is correctly attached, no plasma component is contained in the liquid of the separation circuit 13, and when a plasma separator or the like is erroneously attached, Since the plasma component is contained in the liquid of the separation circuit 13, it is possible to detect an erroneous attachment of the blood purifier by detecting the presence or absence of the plasma component in the liquid of the separation circuit 13 by the optical sensor 51 and the control device 70.

なお、持続的血液濾過療法を行う血液浄化装置1は、血液濾過療法を行う血液浄化装置1と比べるとポンプ流量が低い等の違いはあるものの、基本的な構成は同じである。   The blood purification device 1 that performs continuous blood filtration therapy has the same basic configuration, although there are differences such as a lower pump flow rate than the blood purification device 1 that performs blood filtration therapy.

血液透析療法を行う血液浄化装置1は、例えば図4に示すように透析液回路90が血液濾過器10の中空糸膜20の二次側に接続され、透析液回路90には、透析液ポンプ91、透析液貯留部92が設けられている。血液透析療法では、血液処理の際に透析液貯留部92から透析液回路90を通じて、中空糸膜20の二次側に透析液が供給される。中空糸膜20の二次側に供給された透析液は、血液濾過器10で分離された主に水や老廃物と共に分離回路13を通じて排液される。かかる血液浄化装置1においても、正しく血液濾過器10が取り付けられている場合には、分離回路13の液中に血漿成分が含まれず、誤って血漿分離器等が取り付けられている場合には、分離回路13の液中に血漿成分が含まるので、光センサ51及び制御装置70により、分離回路13の液中の血漿成分の有無を検出することにより、血液浄化器の付け間違いを検出できる。   In the blood purification apparatus 1 that performs hemodialysis therapy, for example, as shown in FIG. 4, a dialysate circuit 90 is connected to the secondary side of the hollow fiber membrane 20 of the hemofilter 10, and the dialysate circuit 90 includes a dialysate pump. 91, a dialysate reservoir 92 is provided. In hemodialysis therapy, dialysate is supplied from the dialysate reservoir 92 to the secondary side of the hollow fiber membrane 20 through the dialysate circuit 90 during blood treatment. The dialysate supplied to the secondary side of the hollow fiber membrane 20 is drained through the separation circuit 13 together with mainly water and waste products separated by the blood filter 10. Also in the blood purification apparatus 1, when the blood filter 10 is correctly attached, no plasma component is contained in the liquid of the separation circuit 13, and when a plasma separator or the like is erroneously attached, Since the plasma component is contained in the liquid of the separation circuit 13, it is possible to detect a mistake in attaching the blood purifier by detecting the presence or absence of the plasma component in the liquid of the separation circuit 13 by the optical sensor 51 and the control device 70.

なお、持続的血液透析療法を行う血液浄化装置1は、血液透析療法を行う血液浄化装置1と比べるとポンプ流量が低い等の違いはあるものの、基本的な構成は同じである。   The blood purification apparatus 1 that performs continuous hemodialysis therapy has the same basic configuration, although the pump flow rate is lower than the blood purification apparatus 1 that performs hemodialysis therapy.

血液濾過透析療法を行う血液浄化装置1は、例えば図5に示すように透析液回路90が血液濾過器10の中空糸膜20の二次側に接続され、補液回路80がドリップチャンバ40に接続されている。その他は、血液濾過療法を行う血液浄化装置1及び血液透析治療を行う血液浄化装置1と同様の構成を有している。血液濾過透析療法では、血液処理の際に透析液貯留部92から透析液回路90を通じて、中空糸膜20の二次側に透析液が供給される。中空糸膜20の二次側に供給された透析液は、血液濾過器10で分離された主に水や老廃物と共に分離回路13を通じて排液される。また、血液処理の際に補液貯留部82から補液回路80を通じて補液が血液に補充される。かかる血液浄化装置1においても、正しく血液濾過器10が取り付けられている場合には、分離回路13の液中に血漿成分が含まれず、誤って血漿分離器等が取り付けられている場合には、分離回路13の液中に血漿成分が含まれるので、光センサ51及び制御装置70により、分離回路13の液中の血漿成分の有無を検出することにより、血液浄化器の付け間違いを検出できる。   In the blood purification apparatus 1 that performs hemofiltration dialysis therapy, for example, as shown in FIG. 5, the dialysate circuit 90 is connected to the secondary side of the hollow fiber membrane 20 of the hemofilter 10, and the replacement fluid circuit 80 is connected to the drip chamber 40. Has been. Others have the same configuration as the blood purification apparatus 1 that performs blood filtration therapy and the blood purification apparatus 1 that performs hemodialysis treatment. In hemofiltration dialysis, dialysate is supplied from the dialysate reservoir 92 to the secondary side of the hollow fiber membrane 20 through the dialysate circuit 90 during blood treatment. The dialysate supplied to the secondary side of the hollow fiber membrane 20 is drained through the separation circuit 13 together with mainly water and waste products separated by the blood filter 10. Further, in the blood treatment, the replacement fluid is replenished to the blood from the replacement fluid reservoir 82 through the replacement fluid circuit 80. Also in the blood purification apparatus 1, when the blood filter 10 is correctly attached, no plasma component is contained in the liquid of the separation circuit 13, and when a plasma separator or the like is erroneously attached, Since the plasma component is contained in the liquid of the separation circuit 13, it is possible to detect an erroneous attachment of the blood purifier by detecting the presence or absence of the plasma component in the liquid of the separation circuit 13 by the optical sensor 51 and the control device 70.

持続的血液濾過透析療法を行う血液浄化装置1は、血液濾過透析療法を行う血液浄化装置1と比べるとポンプ流量が低い等の違いはあるものの、基本的な構成は同じである。   The blood purification apparatus 1 that performs continuous hemodiafiltration therapy has the same basic configuration, although there are differences such as a lower pump flow rate than the blood purification apparatus 1 that performs hemofiltration dialysis therapy.

以上の実施形態は、血液浄化装置1が、血液中の血漿成分以外の主に水分や老廃物を分離する血液濾過器を用いる療法を行うものであったが、本発明は、単純血漿交換療法、二重膜濾過血漿交換療法および血漿吸着療法などの血液中の血漿を交換する療法を行う血液浄化装置1にも適用できる。以下、かかる療法を行う血液浄化装置について説明する。   In the above embodiment, the blood purification apparatus 1 performs therapy using a blood filter that separates mainly water and waste products other than plasma components in blood. However, the present invention provides simple plasma exchange therapy. It can also be applied to the blood purification apparatus 1 that performs a therapy for exchanging plasma in blood, such as a double membrane filtration plasma exchange therapy and a plasma adsorption therapy. Hereinafter, a blood purification apparatus that performs such therapy will be described.

図6に示す血液浄化装置1は、単純血漿交換療法を行うものである。かかる血液浄化装置1は、上述の図3に示した血液濾過療法を行うものとほぼ同じ構成を有しているが、血液濾過器10の代わりに血液中の血漿を分離する血漿分離器100を有し、補液貯留部82の代わりに新鮮凍結血漿貯留部101を有している。血漿分離器100は、血液中の血漿を分離する分離膜として例えば中空糸膜20を有している。   The blood purification apparatus 1 shown in FIG. 6 performs simple plasma exchange therapy. The blood purification apparatus 1 has substantially the same configuration as that for performing the blood filtration therapy shown in FIG. 3 described above, but a plasma separator 100 that separates plasma in blood instead of the blood filter 10 is provided. And a fresh frozen plasma storage unit 101 instead of the replacement fluid storage unit 82. The plasma separator 100 has, for example, a hollow fiber membrane 20 as a separation membrane for separating plasma in blood.

単純血漿交換療法では、患者の血液中の血漿が血漿分離器100により分離され、分離回路13を通じて廃液される。一方、新鮮凍結血漿貯留部101から補液回路80を通じて、血液中に新鮮凍結血漿が注入される。このとき、光センサ51により分離回路13の透過光量がモニタリングされ、その情報が制御装置70に出力され、制御装置70は、その透過光量の情報に基づいて、分離回路13の液中の血漿成分の有無を検出する。単純血漿交換療法において分離回路13で必ず検知されるはずの血漿成分が検出されなかった場合には、制御装置70は、誤った種類の血液浄化器が取り付けられていると判断し、その警報を発する。   In simple plasma exchange therapy, plasma in a patient's blood is separated by a plasma separator 100 and drained through a separation circuit 13. On the other hand, fresh frozen plasma is injected into the blood from the fresh frozen plasma reservoir 101 through the replacement fluid circuit 80. At this time, the amount of light transmitted through the separation circuit 13 is monitored by the optical sensor 51, and the information is output to the control device 70. The control device 70, based on the information on the amount of transmitted light, plasma components in the liquid of the separation circuit 13 The presence or absence of is detected. When the plasma component that should be detected by the separation circuit 13 is not detected in the simple plasma exchange therapy, the control device 70 determines that the wrong type of blood purifier is attached, and gives an alarm. To emit.

本実施の形態によれば、光センサ51及び制御装置70により、分離回路13の液中の血漿成分の有無を検出できるので、血液浄化器の付け間違いを検出できる。よって、目的に合った治療を適正に行うことができる。   According to the present embodiment, since the presence or absence of the plasma component in the liquid of the separation circuit 13 can be detected by the optical sensor 51 and the control device 70, it is possible to detect a mistake in attaching the blood purifier. Therefore, treatment suitable for the purpose can be appropriately performed.

二重濾過血漿浄化療法を行う血液浄化装置1は、例えば図7に示すように血漿分離器100の二次側と血漿成分分離器110の一次側が分離回路13によって接続されている。血漿成分分離器110は、血漿成分を分離する分離膜としての中空糸膜20を有している。血漿成分分離器110の一次側は、ドレイン回路111により廃液容器53に接続されている。ドレイン回路111には、ポンプ112が設けられ、分離回路13には、新たにドリップチャンバ113及び圧力センサ114が設けられている。血漿成分分離器110の二次側は、補液回路80に接続されている。二重濾過血漿浄化療法では、血液処理の際に患者の血液中の血漿が血漿分離器100により分離され、その血漿が血漿成分分離器110により、更に高分子成分と低分子成分に分離される。高分子成分は、ドレイン回路111を通じて廃液され、低分子成分は、補液回路80を通じて血液に戻される。また補液回路80の補液貯留部82から、低分子成分と共に補液が血液に供給される。かかる血液浄化装置1においても、正しく血漿分離器100が取り付けられている場合には、分離回路13の液中に必ず血漿成分が含まれ、誤って血液濾過器が取り付けられている場合には、分離回路13の液中に血漿成分が含まれないので、光センサ51及び制御装置70により、分離回路13の液中の血漿成分の有無を検出することにより、血液浄化器の付け間違いを検出できる。   In the blood purification apparatus 1 that performs double filtration plasma purification therapy, for example, as shown in FIG. 7, the secondary side of the plasma separator 100 and the primary side of the plasma component separator 110 are connected by a separation circuit 13. The plasma component separator 110 has a hollow fiber membrane 20 as a separation membrane that separates plasma components. The primary side of the plasma component separator 110 is connected to the waste liquid container 53 by the drain circuit 111. The drain circuit 111 is provided with a pump 112, and the separation circuit 13 is newly provided with a drip chamber 113 and a pressure sensor 114. The secondary side of the plasma component separator 110 is connected to the replacement fluid circuit 80. In double filtration plasma purification therapy, plasma in a patient's blood is separated by a plasma separator 100 during blood treatment, and the plasma is further separated into a high molecular component and a low molecular component by a plasma component separator 110. . The high molecular component is drained through the drain circuit 111, and the low molecular component is returned to the blood through the replacement fluid circuit 80. In addition, the replacement fluid is supplied to the blood from the replacement fluid reservoir 82 of the replacement fluid circuit 80 together with the low molecular component. In the blood purification apparatus 1 as well, when the plasma separator 100 is correctly attached, the liquid component of the separation circuit 13 always contains plasma components, and when the blood filter is mistakenly attached, Since the plasma component is not contained in the liquid of the separation circuit 13, it is possible to detect an erroneous attachment of the blood purifier by detecting the presence or absence of the plasma component in the liquid of the separation circuit 13 by the optical sensor 51 and the control device 70. .

血漿吸着療法を行う血液浄化装置1は、例えば図8に示すように分離回路13が血漿成分吸着器120に接続され、さらに血漿成分吸着器120が血漿返還回路121によりドリップチャンバ40に接続されている。この血漿吸着療法では、血液処理の際に患者の血液中の血漿が血漿分離器100により分離され、その血漿の所定成分が血漿成分吸着器120により吸着され、残りの血漿が血液に戻される。かかる血液浄化装置1においても、正しく血漿分離器100が取り付けられている場合には、分離回路13の液中に必ず血漿成分が含まれ、誤って血液濾過器が取り付けられている場合には、分離回路13の液中に血漿成分が含まれないので、光センサ51及び制御装置70により、分離回路13の液中の血漿成分の有無を検出することにより、血液浄化器の付け間違いを検出できる。   In the blood purification apparatus 1 that performs plasma adsorption therapy, for example, as shown in FIG. 8, the separation circuit 13 is connected to the plasma component adsorber 120, and the plasma component adsorber 120 is further connected to the drip chamber 40 by the plasma return circuit 121. Yes. In this plasma adsorption therapy, plasma in a patient's blood is separated by the plasma separator 100 during blood treatment, a predetermined component of the plasma is adsorbed by the plasma component adsorber 120, and the remaining plasma is returned to the blood. In the blood purification apparatus 1 as well, when the plasma separator 100 is correctly attached, the liquid component of the separation circuit 13 always contains plasma components, and when the blood filter is mistakenly attached, Since the plasma component is not contained in the liquid of the separation circuit 13, it is possible to detect an erroneous attachment of the blood purifier by detecting the presence or absence of the plasma component in the liquid of the separation circuit 13 by the optical sensor 51 and the control device 70. .

以上、添付図面を参照しながら本発明の好適な実施の形態について説明したが、本発明はかかる例に限定されない。当業者であれば、特許請求の範囲に記載された思想の範疇内において、各種の変更例または修正例に想到し得る事は明らかであり、それらについても当然に本発明の技術的範囲に属するものと了解される。   The preferred embodiments of the present invention have been described above with reference to the accompanying drawings, but the present invention is not limited to such examples. It is obvious for those skilled in the art that various changes or modifications can be conceived within the scope of the idea described in the claims, and these naturally belong to the technical scope of the present invention. It is understood.

例えば血液浄化装置1は、複数の血液浄化療法に応じた複数の血液浄化処理を行うものであってもよい。かかる場合、分離回路13の液に血漿成分が含まれる単純血漿交換療法、二重膜濾過血漿交換療法および血漿吸着療法などの血液浄化処理を行っている場合には、制御装置70は、分離回路13の液に血漿成分が検出されない時に警報を出力する。また、分離回路13の液に血漿成分が含まれない限外濾過療法、血液濾過療法、持続的血液濾過療法、血液透析療法、持続的血液透析療法、血液濾過透析療法および持続的血液濾過透析療法などの血液浄化処理を行っている場合には、制御装置70は、分離回路13の液に血漿成分が検出された時に警報を出力する。   For example, the blood purification apparatus 1 may perform a plurality of blood purification processes according to a plurality of blood purification therapies. In such a case, when performing blood purification processing such as simple plasma exchange therapy in which the plasma component is contained in the liquid of the separation circuit 13, double membrane filtration plasma exchange therapy, and plasma adsorption therapy, the control device 70 includes the separation circuit. An alarm is output when no plasma component is detected in the 13 liquids. In addition, ultrafiltration therapy, hemofiltration therapy, continuous hemofiltration therapy, hemodialysis therapy, continuous hemodialysis therapy, hemofiltration dialysis therapy, and continuous hemofiltration dialysis therapy in which plasma components are not contained in the liquid of the separation circuit 13 When blood purification processing such as the above is performed, the control device 70 outputs an alarm when a plasma component is detected in the liquid of the separation circuit 13.

以上の実施の形態に記載した血液浄化装置1の構成はそれに限られない。血漿成分検出部が有無を検出する所定の血漿成分は、血漿を構成するものであれば特に限定されない。例えば所定の血漿成分は、蛋白質、糖質、脂質、その他無機イオン等であってもよい。
です。
The configuration of the blood purification apparatus 1 described in the above embodiment is not limited thereto. The predetermined plasma component that is detected by the plasma component detection unit is not particularly limited as long as it constitutes plasma. For example, the predetermined plasma component may be protein, carbohydrate, lipid, other inorganic ions, and the like.
is.

本発明は、血液浄化器の付け間違いを検出可能な血液浄化装置を提供する際に有用である。   The present invention is useful in providing a blood purification apparatus capable of detecting a mistake in attaching a blood purification device.

1 血液浄化装置
10 血液濾過器
11 脱血回路
12 返血回路
13 分離回路
20 中空糸膜
31 ドリップチャンバ
32 シリンジポンプ
33 入口圧センサ
40 ドリップチャンバ
41 気泡検知器
42 クランプバルブ
43 静脈圧センサ
50 濾過圧センサ
51 光センサ
52 ポンプ
53 廃液容器
60 発光部
61 受光部
62 支持部材
63 センサ制御部
70 制御装置
71 判定部
72 警報出力部
80 補液回路
81 補液ポンプ
82 補液貯留容器
90 透析液回路
91 透析液ポンプ
92 透析液貯留容器
100 血漿分離器
101 新鮮凍結血漿貯留部
110 血漿成分分離器
111 ドレイン回路
112 ポンプ
113 ドリップチャンバ
114 圧力センサ
120 血漿成分吸着器
121 血漿返還回路
DESCRIPTION OF SYMBOLS 1 Blood purification apparatus 10 Blood filter 11 Blood removal circuit 12 Blood return circuit 13 Separation circuit 20 Hollow fiber membrane 31 Drip chamber 32 Syringe pump 33 Inlet pressure sensor 40 Drip chamber 41 Bubble detector 42 Clamp valve 43 Vein pressure sensor 50 Filtration pressure Sensor 51 Optical sensor 52 Pump 53 Waste liquid container 60 Light emitting part 61 Light receiving part 62 Support member 63 Sensor control part 70 Control device 71 Determination part 72 Alarm output part 80 Fluid replacement circuit 81 Fluid replacement pump 82 Fluid replacement storage container 90 Dialysate circuit 91 Dialysate pump 91 92 Dialysate storage container 100 Plasma separator 101 Fresh frozen plasma storage part 110 Plasma component separator 111 Drain circuit 112 Pump 113 Drip chamber 114 Pressure sensor 120 Plasma component adsorber 121 Plasma return circuit

Claims (6)

血液から所定成分を分離する血液浄化器と、
前記血液浄化器で分離された所定成分の液が流れる分離回路と、
前記分離回路の透過光量を検出するセンサと、
前記センサが検出する透過光量に基づいて、前記分離回路の液中における所定の血漿成分の有無を検出する血漿成分検出部と、を備え
前記血液浄化装置は、前記分離回路の液に前記血漿成分が含まれる血液浄化処理を行うものであり、
前記血液浄化処理時に前記血漿成分検出部により前記血漿成分が検出されない場合に、警報を出す、血液浄化装置。
A blood purifier for separating predetermined components from blood;
A separation circuit through which a liquid of a predetermined component separated by the blood purifier flows;
A sensor for detecting the amount of light transmitted through the separation circuit;
A plasma component detector that detects the presence or absence of a predetermined plasma component in the liquid of the separation circuit based on the amount of transmitted light detected by the sensor ;
The blood purification apparatus performs blood purification processing in which the plasma component is contained in the liquid of the separation circuit,
A blood purification apparatus that issues an alarm when the plasma component detection unit does not detect the plasma component during the blood purification process .
血液から所定成分を分離する血液浄化器と、
前記血液浄化器で分離された所定成分の液が流れる分離回路と、
前記分離回路の透過光量を検出するセンサと、
前記センサが検出する透過光量に基づいて、前記分離回路の液中における所定の血漿成分の有無を検出する血漿成分検出部と、を備え
前記血液浄化装置は、前記分離回路の液に前記血漿成分が含まれない血液浄化処理を行うものであり、
前記血液浄化処理時に前記血漿検出部により前記血漿成分が検出された場合に、警報を出す、血液浄化装置。
A blood purifier for separating predetermined components from blood;
A separation circuit through which a liquid of a predetermined component separated by the blood purifier flows;
A sensor for detecting the amount of light transmitted through the separation circuit;
A plasma component detector that detects the presence or absence of a predetermined plasma component in the liquid of the separation circuit based on the amount of transmitted light detected by the sensor ;
The blood purification apparatus performs blood purification processing in which the plasma component is not contained in the liquid of the separation circuit,
A blood purification apparatus that issues an alarm when the plasma detection unit detects the plasma component during the blood purification process .
血液から所定成分を分離する血液浄化器と、
前記血液浄化器で分離された所定成分の液が流れる分離回路と、
前記分離回路の透過光量を検出するセンサと、
前記センサが検出する透過光量に基づいて、前記分離回路の液中における所定の血漿成分の有無を検出する血漿成分検出部と、を備え
前記血液浄化装置は、複数の血液浄化療法に応じた複数の血液浄化処理を行うものであり、
前記分離回路の液に前記血漿成分が含まれる血液浄化処理を行っている場合には、前記血漿成分検出部により前記血漿成分が検出されない時に警報を出し、
前記分離回路の液に前記血漿成分が含まれない血液浄化処理を行っている場合には、前記血漿成分検出部により前記血漿成分が検出された時に警報を出す、血液浄化装置。
A blood purifier for separating predetermined components from blood;
A separation circuit through which a liquid of a predetermined component separated by the blood purifier flows;
A sensor for detecting the amount of light transmitted through the separation circuit;
A plasma component detector that detects the presence or absence of a predetermined plasma component in the liquid of the separation circuit based on the amount of transmitted light detected by the sensor ;
The blood purification device performs a plurality of blood purification processes according to a plurality of blood purification therapies,
When performing blood purification processing in which the plasma component is contained in the liquid of the separation circuit, an alarm is issued when the plasma component is not detected by the plasma component detection unit,
A blood purification apparatus that issues an alarm when the plasma component is detected by the plasma component detection unit when blood purification processing in which the plasma component is not contained in the liquid of the separation circuit is performed .
前記センサは、波長が200nm〜550nmの透過光を検出するセンサである、請求項1〜3のいずれかに記載の血液浄化装置。 The blood purification apparatus according to any one of claims 1 to 3 , wherein the sensor is a sensor that detects transmitted light having a wavelength of 200 nm to 550 nm. 前記分離回路の液に前記血漿成分が含まれない血液浄化処理は、限外濾過療法、血液濾過療法、血液透析療法、血液濾過透析療法、持続的血液透析療法、持続的血液濾過療法および持続的血液濾過透析療法のいずれかである、請求項2又は3に記載の血液浄化装置。 The blood purification treatment in which the plasma component is not contained in the liquid of the separation circuit includes ultrafiltration therapy, hemofiltration therapy, hemodialysis therapy, hemofiltration dialysis therapy, continuous hemodialysis therapy, continuous hemofiltration therapy and continuous The blood purification apparatus according to claim 2 or 3 , wherein the blood purification apparatus is one of hemofiltration dialysis therapy. 前記分離回路の液に前記血漿成分が含まれる血液浄化処理は、単純血漿交換療法、二重膜濾過血漿交換療法および血漿吸着療法のいずれかである、請求項1又は3に記載の血液浄化装置。 The blood purification apparatus according to claim 1 or 3 , wherein the blood purification process in which the plasma component is contained in the liquid of the separation circuit is one of simple plasma exchange therapy, double membrane filtration plasma exchange therapy, and plasma adsorption therapy. .
JP2014064478A 2014-03-26 2014-03-26 Blood purification equipment Active JP6385095B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2014064478A JP6385095B2 (en) 2014-03-26 2014-03-26 Blood purification equipment
CN201510138237.0A CN104941019B (en) 2014-03-26 2015-03-26 Apparatus for purifying blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014064478A JP6385095B2 (en) 2014-03-26 2014-03-26 Blood purification equipment

Publications (3)

Publication Number Publication Date
JP2015186507A JP2015186507A (en) 2015-10-29
JP2015186507A5 JP2015186507A5 (en) 2017-04-27
JP6385095B2 true JP6385095B2 (en) 2018-09-05

Family

ID=54156429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014064478A Active JP6385095B2 (en) 2014-03-26 2014-03-26 Blood purification equipment

Country Status (2)

Country Link
JP (1) JP6385095B2 (en)
CN (1) CN104941019B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016116100A1 (en) * 2016-08-30 2018-03-01 B. Braun Avitum Ag Detecting device for a medium in a hose section
JP6698558B2 (en) * 2017-01-11 2020-05-27 東レエンジニアリング株式会社 Component concentration detection system
CN109568701A (en) * 2018-12-24 2019-04-05 成都创合丰生物科技有限公司 One kind is for clinical continous way blood component centrifuge separation and treatment system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651059B2 (en) * 1987-06-22 1994-07-06 テルモ株式会社 Hemolysis detector
FR2725522B1 (en) * 1994-10-07 1997-01-03 Hospal Ind DEVICE FOR DETECTING A CONDUIT AND DETERMINING AT LEAST ONE CHARACTERISTIC OF ITS CONTENT
US6348156B1 (en) * 1999-09-03 2002-02-19 Baxter International Inc. Blood processing systems and methods with sensors to detect contamination due to presence of cellular components or dilution due to presence of plasma
DE60220220T2 (en) * 2001-08-10 2008-01-17 KURARAY CO., LTD, Kurashiki Blood treatment system
US6947131B2 (en) * 2002-05-07 2005-09-20 Chf Solutions, Inc. Blood leak detector for extracorporeal treatment system
JP4549229B2 (en) * 2005-05-11 2010-09-22 Junken Medical株式会社 Blood purification system
US8133194B2 (en) * 2006-02-22 2012-03-13 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
JP4936436B2 (en) * 2006-08-23 2012-05-23 日機装株式会社 Blood purification apparatus and method for determining mounting position of blood concentration detecting means thereof
US8187184B2 (en) * 2007-09-21 2012-05-29 Baxter International, Inc. Access disconnect system with optical and other sensors
DE102009036044A1 (en) * 2009-08-04 2011-02-10 Fresenius Medical Care Deutschland Gmbh Device and method for detecting blood or blood components in the fluid system of an apparatus for extracorporeal blood treatment
CN101762561B (en) * 2009-11-10 2012-06-06 浙江天元生物药业有限公司 Method for on-line detecting integrity of ultrafiltration membrane by using ultraviolet monitoring method
JP5816014B2 (en) * 2011-07-14 2015-11-17 旭化成メディカル株式会社 Plasma purification apparatus and method of operating plasma purification apparatus
CN102600521A (en) * 2012-03-19 2012-07-25 王天欣 Device and method for eliminating pathogens in blood
CN203329103U (en) * 2013-06-03 2013-12-11 上海市同济医院 Double-pump hemodialysis machine used for conducting plasma adsorption treatment

Also Published As

Publication number Publication date
JP2015186507A (en) 2015-10-29
CN104941019A (en) 2015-09-30
CN104941019B (en) 2017-07-14

Similar Documents

Publication Publication Date Title
JP7171828B2 (en) Blood treatment system and method
US10195336B2 (en) Blood purification apparatus and priming method thereof
JP3958733B2 (en) Blood purification equipment
JP6685089B2 (en) Medical fluid pressure detector
CN102186514B (en) Method and device for monitoring the introduction of substitution fluids upstream or downstream of a dialyzer or filter
CA2939155A1 (en) Portable hemodialysis machine and disposable cartridge
WO2008065950A1 (en) State detecting device
CN101687069A (en) Hemodialyzer
US8875748B2 (en) Device for filling a filter, and method therefor
US10940253B2 (en) Blood purification apparatus
KR20160095145A (en) Extracorporeal blood treatment system, disposable set and valve unit for pre/post infusion
JP6385095B2 (en) Blood purification equipment
US10940252B2 (en) Blood purification apparatus
JP5981987B2 (en) Extracorporeal blood treatment apparatus and method for monitoring liquid flow in extracorporeal blood treatment apparatus
JP4757168B2 (en) Method for feeding back-filtered dialysate in hemodialyzer and hemodialyzer
JP4854374B2 (en) Extracorporeal circulation device, extracorporeal circulation circuit, method for confirming connection state of pressure measurement line and pressure measurement means
JP5816014B2 (en) Plasma purification apparatus and method of operating plasma purification apparatus
JP5514606B2 (en) Continuous hemodialysis machine
JP2015186507A5 (en)
EP2550987A1 (en) Dialysis machine with haemolysis control
CN113350593A (en) Control method of blood purification apparatus, and storage medium
JP2016112089A (en) Blood purification system and blood purifier
JPWO2018180032A1 (en) Blood purification apparatus, control method therefor, and method for eliminating poor blood removal
JP2008036304A (en) Blood purifying device and method for determining position of mounting its blood concentration detecting means
JP2018171340A (en) Blood purification device, control method thereof and blood removal failure solution method

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170323

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180124

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180126

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180326

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180802

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180807

R150 Certificate of patent or registration of utility model

Ref document number: 6385095

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350